Drugs / bivalent OPV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01586572 | Apr 2012 → May 2013 | poliomyelitis | Aga Khan University | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bivalent OPV | “two doses of bivalent OPV (bOPV) with an interval of 4 weeks between doses (bOPV-4 weeks)” PMID 26093979 ↗ Jun 2015 |
| Known as | bOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01586572 ↗ |
| Modality | Vaccine | “The bivalent oral polio vaccine containing at least 106 CCID50 of Sabin poliovirus type 1 and 105•8 CCID50 of Sabin poliovirus type 3.” NCT01586572 ↗ |
| Route | Oral | “The bivalent oral polio vaccine containing at least 106 CCID50 of Sabin poliovirus type 1 and 105•8 CCID50 of Sabin poliovirus type 3.” NCT01586572 ↗ |